Literature DB >> 18579580

Association study of the NEDD9 gene with the risk of developing Alzheimer's and Parkinson's disease.

Julien Chapuis1, Frédéric Moisan, Georges Mellick, Alexis Elbaz, Peter Silburn, Florence Pasquier, Didier Hannequin, Corinne Lendon, Dominique Campion, Philippe Amouyel, Jean-Charles Lambert.   

Abstract

Alzheimer's disease (AD) and Parkinson's disease (PD), the two most common neurodegenerative disorders in the elderly, have been hypothesized to share genetic determinants. Recently, Li et al. proposed that a variant in the NEDD9 gene may be one of these common genetic factors. We attempted to confirm this initial observation by conducting an equivalent analysis in terms of pathologies and sample size. We genotyped the NEDD9 rs760678 SNP in three independent AD case-control studies (n = 3176) and two independent PD case-control studies (n = 1855). However, we failed to detect an association of this SNP with the risk of developing AD or PD, in any of these populations. In conclusion, these data indicate that the rs760678 SNP of the NEDD9 gene is at best a weak genetic determinant of AD or PD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18579580     DOI: 10.1093/hmg/ddn183

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  9 in total

Review 1.  Preclinical and clinical studies of the NEDD9 scaffold protein in cancer and other diseases.

Authors:  Elena Shagisultanova; Anna V Gaponova; Rashid Gabbasov; Emmanuelle Nicolas; Erica A Golemis
Journal:  Gene       Date:  2015-05-09       Impact factor: 3.688

2.  Is the urea cycle involved in Alzheimer's disease?

Authors:  Franck Hansmannel; Adeline Sillaire; M Ilyas Kamboh; Corinne Lendon; Florence Pasquier; Didier Hannequin; Geoffroy Laumet; Anais Mounier; Anne-Marie Ayral; Steven T DeKosky; Jean-Jacques Hauw; Claudine Berr; David Mann; Philippe Amouyel; Dominique Campion; Jean-Charles Lambert
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 3.  CAS proteins in normal and pathological cell growth control.

Authors:  Nadezhda Tikhmyanova; Joy L Little; Erica A Golemis
Journal:  Cell Mol Life Sci       Date:  2009-11-25       Impact factor: 9.261

4.  Mid-gestational gene expression profile in placenta and link to pregnancy complications.

Authors:  Liis Uusküla; Jaana Männik; Kristiina Rull; Ave Minajeva; Sulev Kõks; Pille Vaas; Pille Teesalu; Jüri Reimand; Maris Laan
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

Review 5.  Shared mechanisms of neurodegeneration in Alzheimer's disease and Parkinson's disease.

Authors:  Anmu Xie; Jing Gao; Lin Xu; Dongmei Meng
Journal:  Biomed Res Int       Date:  2014-05-12       Impact factor: 3.411

Review 6.  Review: The genetics of Alzheimer's disease; putting flesh on the bones.

Authors:  C Medway; K Morgan
Journal:  Neuropathol Appl Neurobiol       Date:  2014-02       Impact factor: 8.090

7.  Adaptors for disorders of the brain? The cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer's disease.

Authors:  Tim N Beck; Emmanuelle Nicolas; Meghan C Kopp; Erica A Golemis
Journal:  Oncoscience       Date:  2014-07-23

8.  Transforming growth factor beta promotes neuronal cell fate of mouse cortical and hippocampal progenitors in vitro and in vivo: identification of Nedd9 as an essential signaling component.

Authors:  Tanja Vogel; Sandra Ahrens; Nicole Büttner; Kerstin Krieglstein
Journal:  Cereb Cortex       Date:  2009-07-08       Impact factor: 5.357

9.  Gene-based testing of interactions in association studies of quantitative traits.

Authors:  Li Ma; Andrew G Clark; Alon Keinan
Journal:  PLoS Genet       Date:  2013-02-28       Impact factor: 5.917

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.